Search Within

Michael Joseph Cavnar

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (1)
Groups
  1. Department of Pathology and Laboratory Medicine (10)
  2. GSK Faculty (10)
  3. Surgery (10)
  4. Center for Pancreatic Cancer Research (9)
  5. Human Oncology and Pathogenesis Program (9)
  6. Tow Center for Developmental Oncology (TCDO) (9)

More Groups

People
  1. Ronald DeMatteo (10)
  2. Cristina Antonescu (9)
  3. Vinod Balachandran (9)
  4. Samuel Singer (5)
  5. William Tap (5)
  6. Ferdinando Rossi (4)

More People

Years
  1. 2021 (2)
  2. 2019 (1)
  3. 2017 (3)
  4. 2014 (1)
  5. 2013 (2)
  6. 2011 (1)
Publications
  1. Annals of Surgical Oncology (4)
  2. Annals of Surgery (1)
  3. Clinical Cancer Research (1)
  4. Journal of Experimental Medicine (1)
  5. Journal of Gastrointestinal Surgery (1)
  6. Molecular Cancer Therapeutics (1)

More Publications

Publishers
  1. Springer (5)
  2. American Association for Cancer Research (2)
  3. Lippincott Williams & Wilkins (1)
  4. Nature Publishing Group (1)
  5. Rockefeller University Press (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic factors after neoadjuvant imatinib for newly diagnosed primary gastrointestinal stromal tumor
    Journal Article

    Cavnar, M. J.; Seier, K.; Gönen, M.; Curtin, C.; Balachandran, V. P.; Tap, W. D.; Antonescu, C. R.; Singer, S.; DeMatteo, R. P.
    Journal of Gastrointestinal Surgery (2021)

    Fulltext@MSK | Save
  • Outcome of 1000 patients with gastrointestinal stromal tumor (GIST) treated by surgery in the pre- and post-imatinib eras
    Journal Article

    Cavnar, M. J.; Seier, K.; Curtin, C.; Balachandran, V. P.; Coit, D. G.; Yoon, S. S.; Crago, A. M.; Strong, V. E.; Tap, W. D.; Gönen, M.; more...
    Annals of Surgery (2021)

    Fulltext@MSK | Save
  • Tumor mitotic rate after neoadjuvant imatinib is associated with outcome in primary gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Cavnar, M. J.; Seier, K.; Mithat, G.; Balachandran, V. P.; Curtin, C.; Keohan, M.; Tap, W.; Antonescu, C.; Singer, S.; DeMatteo, R. P.
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • Rectal gastrointestinal stromal tumor (GIST) in the era of imatinib: Organ preservation and improved oncologic outcome
    Journal Article

    Cavnar, M. J.; Wang, L.; Balachandran, V. P.; Antonescu, C. R.; Tap, W. D.; Keohan, M.; Singer, S.; Temple, L.; Nash, G. M.; Weiser, M. R.; more...
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • Wnt/β-catenin signaling contributes to tumor malignancy and is targetable in gastrointestinal stromal tumor
    Journal Article

    Zeng, S.; Seifert, A. M.; Zhang, J. Q.; Cavnar, M. J.; Kim, T. S.; Balachandran, V. P.; Santamaria-Barria, J. A.; Cohen, N. A.; Beckman, M. J.; Medina, B. D.; more...
    Molecular Cancer Therapeutics (2017)

    Fulltext@MSK | Save
  • Tumor-associated macrophage infiltration in colorectal cancer liver metastases is associated with better outcome
    Journal Article

    Cavnar, M. J.; Turcotte, S.; Katz, S. C.; Kuk, D.; Gönen, M.; Shia, J.; Allen, P. J.; Balachandran, V. P.; D’Angelica, M. I.; Kingham, T. P.; more...
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor
    Journal Article

    Kim, T. S.; Cavnar, M. J.; Cohen, N. A.; Sorenson, E. C.; Greer, J. B.; Seifert, A. M.; Crawley, M. H.; Green, B. L.; Popow, R.; Pillarsetty, N.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • KIT oncogene inhibition drives intratumoral macrophage M2 polarization
    Journal Article

    Cavnar, M. J.; Zeng, S.; Kim, T. S.; Sorenson, E. C.; Ocuin, L. M.; Balachandran, V. P.; Seifert, A. M.; Greer, J. B.; Popow, R.; Crawley, M. H.; more...
    Journal of Experimental Medicine (2013)

    Fulltext@MSK | Save
  • Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor
    Journal Article

    Perez, D. R.; Baser, R. E.; Cavnar, M. J.; Balachandran, V. P.; Antonescu, C. R.; Tap, W. D.; Strong, V. E.; Brennan, M. F.; Coit, D. G.; Singer, S.; more...
    Annals of Surgical Oncology (2013)

    Fulltext@MSK | Save
  • Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
    Journal Article

    Balachandran, V. P.; Cavnar, M. J.; Zeng, S.; Bamboat, Z. M.; Ocuin, L. M.; Obaid, H.; Sorenson, E. C.; Popow, R.; Ariyan, C.; Rossi, F.; more...
    Nature Medicine (2011)

    Fulltext@MSK | Save